These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 24008133)

  • 21. Synthesis of trans-bis-(2-hydroxypyridine)dichloroplatinum(II) and its activity in human ovarian tumour models.
    Deqnah N; Yu JQ; Beale P; Fisher K; Huq F
    Anticancer Res; 2012 Jan; 32(1):135-40. PubMed ID: 22213298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA interactions of new antitumor platinum complexes with trans geometry activated by a 2-metylbutylamine or sec-butylamine ligand.
    Prokop R; Kasparkova J; Novakova O; Marini V; Pizarro AM; Navarro-Ranninger C; Brabec V
    Biochem Pharmacol; 2004 Mar; 67(6):1097-109. PubMed ID: 15006546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reversion of structure-activity relationships of antitumor platinum complexes by acetoxime but not hydroxylamine ligands.
    Zorbas-Seifried S; Jakupec MA; Kukushkin NV; Groessl M; Hartinger CG; Semenova O; Zorbas H; Kukushkin VY; Keppler BK
    Mol Pharmacol; 2007 Jan; 71(1):357-65. PubMed ID: 17050805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism-related circumvention of acquired cis-diamminedichloroplatinum(II) resistance using two pairs of human ovarian carcinoma cell lines by ammine/amine platinum(IV) dicarboxylates.
    Kelland LR; Mistry P; Abel G; Loh SY; O'Neill CF; Murrer BA; Harrap KR
    Cancer Res; 1992 Jul; 52(14):3857-64. PubMed ID: 1617660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis, structure, and reactivity of monofunctional platinum(II) and palladium(II) complexes containing the sterically hindered ligand 6-(methylpyridin-2-yl)acetate.
    Ma Y; Day CS; Bierbach U
    J Inorg Biochem; 2005 Oct; 99(10):2013-23. PubMed ID: 16087242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trans-platinum complexes in cancer therapy.
    Coluccia M; Natile G
    Anticancer Agents Med Chem; 2007 Jan; 7(1):111-23. PubMed ID: 17266508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platinum(II) complexes containing iminoethers: a trans platinum antitumour agent.
    Coluccia M; Boccarelli A; Mariggiò MA; Cardellicchio N; Caputo P; Intini FP; Natile G
    Chem Biol Interact; 1995 Dec; 98(3):251-66. PubMed ID: 8548863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA interactions of a novel platinum drug, cis-[PtCl(NH3)2(N7-acyclovir)]+.
    Balcarová Z; Kaspárková J; Zákovská A; Nováková O; Sivo MF; Natile G; Brabec V
    Mol Pharmacol; 1998 May; 53(5):846-55. PubMed ID: 9584210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monofunctional platinum amine complexes destabilize DNA significantly.
    Bauer C; Peleg-Shulman T; Gibson D; Wang AH
    Eur J Biochem; 1998 Sep; 256(2):253-60. PubMed ID: 9760162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trans-diammineplatinum(II): what makes it different from cis-DDP? Coordination chemistry of a neglected relative of cisplatin and its interaction with nucleic acids.
    Lippert B
    Met Ions Biol Syst; 1996; 33():105-41. PubMed ID: 8742842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytotoxicity, mutagenicity, cellular uptake, DNA and glutathione interactions of lipophilic trans-platinum complexes tethered to 1-adamantylamine.
    Halámiková A; Heringová P; Kaspárková J; Intini FP; Natile G; Nemirovski A; Gibson D; Brabec V
    J Inorg Biochem; 2008; 102(5-6):1077-89. PubMed ID: 18237783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA modifications by antitumor trans-[PtCl2(E-iminoether)2].
    Zaludová R; Zákovská A; Kaspárkova J; Balcarová Z; Vrána O; Coluccia M; Natile G; Brabec V
    Mol Pharmacol; 1997 Sep; 52(3):354-61. PubMed ID: 9281596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction and repair of DNA cross-links in chinese hamster ovary cells treated with various platinum coordination compounds in relation to platinum binding to DNA, cytotoxicity, mutagenicity, and antitumor activity.
    Plooy AC; van Dijk M; Lohman PH
    Cancer Res; 1984 May; 44(5):2043-51. PubMed ID: 6538808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
    Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
    Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cisplatin and transplatin interaction with methionine: bonding motifs assayed by vibrational spectroscopy in the isolated ionic complexes.
    Paciotti R; Corinti D; De Petris A; Ciavardini A; Piccirillo S; Coletti C; Re N; Maitre P; Bellina B; Barran P; Chiavarino B; Elisa Crestoni M; Fornarini S
    Phys Chem Chem Phys; 2017 Oct; 19(39):26697-26707. PubMed ID: 28876340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel apoptosis-inducing trans-platinum piperidine derivatives: synthesis and biological characterization.
    Khazanov E; Barenholz Y; Gibson D; Najajreh Y
    J Med Chem; 2002 Nov; 45(24):5196-204. PubMed ID: 12431047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systematic differences in electrochemical reduction of the structurally characterized anti-cancer platinum(IV) complexes [Pt{((p-HC6F4)NCH2)2}-(pyridine)2Cl2], [Pt{((p-HC6F4)NCH2)2}(pyridine)2(OH)2], and [Pt{((p-HC6F4)NCH2)2}(pyridine)2(OH)Cl].
    Guo SX; Mason DN; Turland SA; Lawrenz ET; Kelly LC; Fallon GD; Gatehouse BM; Bond AM; Deacon GB; Battle AR; Hambley TW; Rainone S; Webster LK; Cullinane C
    J Inorg Biochem; 2012 Oct; 115():226-39. PubMed ID: 22921430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recognition of DNA modified by trans-[PtClNH(4-hydroxymethylpyridine)] by tumor suppressor protein p53 and character of DNA adducts of this cytotoxic complex.
    Stehlíková K; Kaspárková J; Nováková O; Martínez A; Moreno V; Brabec V
    FEBS J; 2006 Jan; 273(2):301-14. PubMed ID: 16403018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Steric control of DNA interstrand cross-link sites of trans platinum complexes: specificity can be dictated by planar nonleaving groups.
    Brabec V; Neplechova K; Kasparkova J; Farrell N
    J Biol Inorg Chem; 2000 Jun; 5(3):364-8. PubMed ID: 10907747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of the geometry of the central coordination sphere in antitumor trinuclear platinum complexes on DNA binding.
    Kasparkova J; Vrana O; Farrell N; Brabec V
    J Inorg Biochem; 2004 Oct; 98(10):1560-9. PubMed ID: 15458817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.